IRIS
GALLO, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.105
NA - Nord America 373
EU - Europa 241
AF - Africa 7
SA - Sud America 6
OC - Oceania 4
Totale 4.736
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 3.718
US - Stati Uniti d'America 357
HK - Hong Kong 180
CN - Cina 173
IT - Italia 81
GB - Regno Unito 43
DE - Germania 33
NL - Olanda 26
CZ - Repubblica Ceca 15
FI - Finlandia 15
CA - Canada 11
IN - India 11
FR - Francia 6
PL - Polonia 6
TR - Turchia 6
UA - Ucraina 6
ZA - Sudafrica 6
AT - Austria 4
ID - Indonesia 4
MX - Messico 4
AU - Australia 3
BR - Brasile 3
BE - Belgio 2
CL - Cile 2
JP - Giappone 2
KR - Corea 2
KZ - Kazakistan 2
PH - Filippine 2
VN - Vietnam 2
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CH - Svizzera 1
ES - Italia 1
ET - Etiopia 1
HN - Honduras 1
HU - Ungheria 1
KI - Kiribati 1
SA - Arabia Saudita 1
SE - Svezia 1
Totale 4.736
Salva come PNG Salva come JPEG
Città #
Hong Kong 176
Singapore 164
Ashburn 88
Hefei 80
Shanghai 66
Boardman 61
Rome 47
London 34
Munich 17
Brno 15
Amsterdam 14
Los Angeles 14
San Francisco 14
Seattle 12
Turku 11
Santa Clara 9
Council Bluffs 8
Pune 8
Toronto 8
New York 7
Warsaw 6
Brooklyn 4
Guangzhou 4
Helsinki 4
Washington 4
Boston 3
Brownsville 3
Canberra 3
Johannesburg 3
Mexico City 3
Vienna 3
Arayat 2
Atlanta 2
Bari 2
Buffalo 2
Camden 2
Central 2
Chicago 2
Ho Chi Minh City 2
Kharkiv 2
Liverpool 2
Messina 2
Paris 2
Perugia 2
São Paulo 2
Tokyo 2
Wembley 2
Almere Stad 1
Augusta 1
Budapest 1
Changchun 1
Changsha 1
Charleston 1
Chennai 1
Cleveland 1
Cold Lake 1
Dallas 1
Dongguan 1
Foggia 1
Foligno 1
Frankfurt am Main 1
Genoa 1
Handan 1
Helena 1
Houston 1
Hyderabad 1
Jinan 1
Koekelberg 1
Las Vegas 1
Manchester 1
Markham 1
Montpellier 1
Montreal 1
Nanyang 1
Pasadena 1
Pingxiang 1
Pittsburgh 1
Providence 1
Redmond 1
Rockville 1
Salt Lake City 1
Shenzhen 1
Siena 1
Slough 1
Stockholm 1
Tarawa 1
Tegucigalpa 1
The Dalles 1
Trieste 1
Turin 1
Wuxi 1
Xingtai 1
Xuzhou 1
Zhengzhou 1
Totale 972
Salva come PNG Salva come JPEG
Nome #
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 193
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 193
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 189
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 185
Impairment of GH/IGF-1 Axis in the liver of patients with hcv-related chronic hepatitis 182
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 179
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 179
Hepatitis A virus in a medical setting in Madagascar: a lesson for public health 172
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 170
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 168
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 167
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 167
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 164
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 164
Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis 159
Safety of Sofosbuvir-Based Direct-Acting Antivirals for Hepatitis C Virus Infection and Direct Oral Anticoagulant Co-Administration 154
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 90
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 82
A challenging alfa-fetoprotein in a cirrhotic patient 80
ALT levels are associated with metabolic parameters and age in a large real-life population. 80
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 79
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 76
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 76
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 75
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 73
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 70
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 66
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 62
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 57
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 56
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 54
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 51
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 45
Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers 43
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 42
Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience 31
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 29
Individuation of presence and combination of genetic risk factors may help to refine the risk for most severe forms of NAFLD 28
Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures 26
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 26
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management 24
Sarcopenia in Chronic Liver Disease: The Emerging Role of Ultrasound in Determining Muscle Mass, Strength and Clinical Outcomes 22
Renal impairment and anemia during triple therapy 22
Pain and Frailty in Hospitalized Older Adults 22
Reply to the Letter: “Low levels of transaminase and mortality risk in older people with special reference to sarcopenia” 22
Telaprevir raises the plasma/whole blood ribavirin ratio: trying to come full circle on a dangerous relationship 21
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 21
What changed in the Italian internal medicine and geriatric wards during the lockdown 21
Potentially inappropriate medications, drug–drug interactions, and anticholinergic burden in elderly hospitalized patients: does an association exist with post-discharge health outcomes? 19
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 18
Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis 18
The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention 17
Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD) 17
Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables 17
Multimorbidity and polypharmacy in the elderly: lessons from REPOSI 17
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy 17
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 16
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 16
Steroid-refractory immune related hepatitis may hide viral re-activation 16
Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge 15
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 15
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 14
Prevalence of patatin-like phospholipase domain containing 3 (PNPLA3) rs738409 C/G polymorphism in patients with bona-fide post-NASH cirrhosis 14
Gender-differences in disease distribution and outcome in hospitalized elderly: data from the REPOSI study 14
Non‐invasive assessment of hepatic steatosis by ultrasound‐derived fat fraction in individuals at high‐risk for metabolic dysfunction‐associated steatotic liver disease 13
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 13
Platelet count may impact on lysosomal acid lipase activity determination in dried blood spot 13
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study 13
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 13
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 12
Liver Cirrhosis is Characterized by an Acquired Lysosomal Acid Lipase Deficiency Independent from the Etiology of Liver Disease 12
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis 11
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 11
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients 11
Editorial: Clinical management of older persons with sarcopenia: current status and future directions 10
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 9
Percutaneous electrochemotherapy in the treatment of portal vein tumor thrombosis at hepatic hilum in patients with hepatocellular carcinoma in cirrhosis: A feasibility study 8
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 8
Prevalence of anti-hepatitis C positivity in a nursing home: a hitherto unrecognized submerged population 8
Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Modern Context for an Ancient Disease 7
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 4
Totale 4.793
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.261
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.261
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202290 0 0 2 0 1 0 2 2 12 0 2 69
2022/202319 0 0 0 0 1 2 5 1 1 3 6 0
2023/2024176 6 14 4 23 13 78 2 6 3 6 5 16
2024/20254.457 38 16 66 12 129 98 77 14 176 263 1.749 1.819
2025/202651 51 0 0 0 0 0 0 0 0 0 0 0
Totale 4.793